CLOSED - Clinical Trial on Secondary Progressive Multiple Sclerosis Varies

Clinical Trial on Secondary Progressive Multiple Sclerosis

Description

A local research facility is seeking participants for a clinical research study on Secondary Progressive Multiple Sclerosis. This is a clinical research study to test the safety and effectiveness of an investigational medication that may help delay disability worsening in patients with non-relapsing Secondary Progressive Multiple Sclerosis (nr-SPMS).

 

Total study duration, including screening, is approximately 4.5 years with up to 27 doctor’s visits. Visit frequency will be every month for the first 6 months and then every 3 months.

 

Trial-related procedures and study medication will be provided at no cost.


Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.

Other focus groups: